Akira Anan

623 total citations
33 papers, 432 citations indexed

About

Akira Anan is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Akira Anan has authored 33 papers receiving a total of 432 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Hepatology, 21 papers in Epidemiology and 9 papers in Surgery. Recurrent topics in Akira Anan's work include Liver Disease Diagnosis and Treatment (18 papers), Liver Disease and Transplantation (8 papers) and Hepatitis C virus research (8 papers). Akira Anan is often cited by papers focused on Liver Disease Diagnosis and Treatment (18 papers), Liver Disease and Transplantation (8 papers) and Hepatitis C virus research (8 papers). Akira Anan collaborates with scholars based in Japan, United States and Germany. Akira Anan's co-authors include Makoto Irie, Tetsuro Sohda, Gregory J. Gores, Edwina Baskin-Bey, Steven F. Bronk, Vijay H. Shah, Nathan W. Werneburg, Shotaro Sakisaka, Kaoru Iwata and Takashi Tanaka and has published in prestigious journals such as SHILAP Revista de lepidopterología, Hepatology and Medicine.

In The Last Decade

Akira Anan

32 papers receiving 411 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Akira Anan Japan 12 274 271 120 74 57 33 432
Roman Liebe Germany 11 192 0.7× 260 1.0× 105 0.9× 135 1.8× 73 1.3× 36 468
F Thieringer Germany 10 226 0.8× 186 0.7× 63 0.5× 112 1.5× 54 0.9× 11 422
Tae Jun Park South Korea 5 338 1.2× 252 0.9× 167 1.4× 84 1.1× 67 1.2× 15 485
Marco Sanduzzi‐Zamparelli Spain 10 268 1.0× 233 0.9× 60 0.5× 66 0.9× 78 1.4× 30 424
Kota Tsuruya Japan 13 206 0.8× 175 0.6× 99 0.8× 60 0.8× 77 1.4× 46 408
Sawako Uchida‐Kobayashi Japan 11 293 1.1× 262 1.0× 54 0.5× 69 0.9× 99 1.7× 59 474
Jong Ryul Eun South Korea 15 304 1.1× 269 1.0× 89 0.7× 84 1.1× 106 1.9× 41 528
Giulia Negrini Italy 11 178 0.6× 195 0.7× 125 1.0× 55 0.7× 62 1.1× 13 447
Tsukasa Kawaguchi Japan 8 159 0.6× 201 0.7× 83 0.7× 57 0.8× 28 0.5× 9 326
Toshiya Osawa Japan 9 215 0.8× 188 0.7× 67 0.6× 74 1.0× 78 1.4× 22 373

Countries citing papers authored by Akira Anan

Since Specialization
Citations

This map shows the geographic impact of Akira Anan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akira Anan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akira Anan more than expected).

Fields of papers citing papers by Akira Anan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akira Anan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akira Anan. The network helps show where Akira Anan may publish in the future.

Co-authorship network of co-authors of Akira Anan

This figure shows the co-authorship network connecting the top 25 collaborators of Akira Anan. A scholar is included among the top collaborators of Akira Anan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akira Anan. Akira Anan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Takata, Kazuhide, et al.. (2019). Magnetic resonance cholangiopancreatography for afferent loop syndrome. SHILAP Revista de lepidopterología. 7(3). 591–592. 2 indexed citations
3.
Morihara, Daisuke, Takashi Tanaka, Keiji Yokoyama, et al.. (2017). Hepatic Pseudolymphoma with an Occult Hepatitis B Virus Infection. Internal Medicine. 57(2). 223–230. 11 indexed citations
4.
Irie, Makoto, Tetsuro Sohda, Akira Anan, et al.. (2016). Reduced Glutathione suppresses Oxidative Stress inNonalcoholic Fatty Liver Disease. Euroasian Journal of Hepato-Gastroenterology. 6(1). 13–18. 38 indexed citations
5.
Iwata, Kaoru, Akira Anan, Tetsuro Sohda, et al.. (2015). Why is radiofrequency ablation therapy applied for hepatocellular carcinoma up to 3 nodules and smaller than 3 cm in tumor size?. PubMed. 61(136). 2305–10. 5 indexed citations
6.
Yokoyama, Keiji, Akira Anan, Kaoru Iwata, et al.. (2012). Limitation of repeated radiofrequency ablation in hepatocellular carcinoma: Proposal of a three (times) ×  3 (years) index. Journal of Gastroenterology and Hepatology. 27(6). 1044–1050. 9 indexed citations
7.
Shakado, Satoshi, Yuko Akehi, Atsushi Fukunaga, et al.. (2011). A case of hepatitis C-associated osteosclerosis that was improved with the combination therapy of peginterferon alfa-2b and ribavirin. Clinical Journal of Gastroenterology. 4(4). 255–261. 3 indexed citations
8.
Irie, Makoto, Keiji Yokoyama, Daisuke Morihara, et al.. (2010). Patient with drug-induced hepatic injury with sever bilirubinemia due to long-term administration of Amlodipine and Loxoprofen Na. Kanzo. 51(4). 169–174.
9.
Morihara, Daisuke, Yasuaki Takeyama, Shinya Nishizawa, et al.. (2009). A Case of Acute Pancreatitis Associated with a Severe Acute HAV Infection and Compensated Liver Cirrhosis Type B. 36(2). 135–139. 1 indexed citations
10.
Tanaka, Takashi, Satoshi Shakado, Daisuke Morihara, et al.. (2008). The prognostic factors of sustained virologic response among patients of chronic hepatitis C treated with peg-interferon alpha 2a monotherapy. Kanzo. 49(9). 417–425. 3 indexed citations
11.
Takeyama, Yasuaki, Takashi Tanaka, Shuichi Ueda, et al.. (2008). Budd-Chiari Syndrome: Two Cases with Different Courses. Case Reports in Gastroenterology. 2(2). 256–261. 1 indexed citations
12.
Shakado, Satoshi, Hiroshi Watanabe, Takashi Tanaka, et al.. (2008). Combination therapy of lamivudine and adefovir in Japanese patients with chronic hepatitis B. Hepatology International. 2(3). 361–369. 8 indexed citations
13.
Tanaka, Yoïchi, Tetsuro Sohda, Katsuhiko Matsuo, et al.. (2007). Vascular endothelial growth factor reduces Fas‐mediated acute liver injury in mice. Journal of Gastroenterology and Hepatology. 23(7pt2). e207–11. 8 indexed citations
14.
Sohda, Tetsuro, Kaoru Iwata, Yuji Kitamura, et al.. (2007). Reduced expression of low‐density lipoprotein receptor in hepatocellular carcinoma with paraneoplastic hypercholesterolemia. Journal of Gastroenterology and Hepatology. 23(7pt2). e153–6. 18 indexed citations
15.
Anan, Akira, Makoto Irie, Hiroshi Watanabe, et al.. (2006). Colonic varices treated by balloon-occluded retrograde transvenous obliteration in a cirrhotic patient with encephalopathy: a case report. Gastrointestinal Endoscopy. 63(6). 880–884. 27 indexed citations
16.
Anan, Akira, Edwina Baskin-Bey, Steven F. Bronk, et al.. (2006). Proteasome inhibition induces hepatic stellate cell apoptosis. Hepatology. 43(2). 335–344. 110 indexed citations
17.
Anan, Akira, Edwina Baskin-Bey, Hajime Isomoto, et al.. (2006). Proteasome inhibition attenuates hepatic injury in the bile duct-ligated mouse. American Journal of Physiology-Gastrointestinal and Liver Physiology. 291(4). G709–G716. 27 indexed citations
18.
Matsumoto, Teruo, Hiroshi Watanabe, Makoto Irie, et al.. (2004). Nonalcoholic steatohepatitis associated with psoriasis vulgaris. Journal of Gastroenterology. 39(11). 1102–1105. 14 indexed citations
19.
Yokoyama, Keiji, Kaoru Iwata, Makoto Irie, et al.. (2004). Hepatocellular Carcinoma in a Patient with Liver Cirrhosis Associated with Negative Serum HCV Tests but Positive Liver Tissue HCV RNA. Internal Medicine. 43(4). 279–282. 18 indexed citations
20.
K, Ota, Masatoshi Okazaki, Hideyuki Higashihara, et al.. (1999). Combination of transileocolic vein obliteration and balloon-occluded retrograde transvenous obliteration is effective for ruptured duodenal varices. Journal of Gastroenterology. 34(6). 694–699. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026